8K7.SI stock down 5.06% pre-market to S$0.075 on 18 Mar 2026: watch forecast

UG Healthcare Corporation Limited (8K7.SI) fell in pre-market trade on 18 Mar 2026, sliding 5.06% to S$0.075 as volume accelerated to 935700 shares. The move makes 8K7.SI stock one of the top losers in the Singapore Exchange (SES) early session, testing the year low band. Traders cite weak near-term momentum and still-negative EPS of -0.01 as headwinds. We examine price drivers, fundamentals and short-term forecasts to show what to watch next

8K7.SI stock: Pre-market price action and market data

UG Healthcare (8K7.SI) opened S$0.077 and trades at S$0.075 pre-market on 18 Mar 2026. The one-day decline is -5.06%, day low S$0.073 and day high S$0.078. Volume of 935700 beats the average daily volume of 738747, signalling heavier selling pressure today The market cap stands at S$46.79m and shares outstanding are 623,825,811. Recent trend data show YTD change -20.21% and 1‑year change -33.63%, aligning with the stock’s appearance among top losers this session.

8K7.SI stock: Fundamental snapshot and valuation

UG Healthcare reports EPS -0.01 and PE of -7.50, reflecting negative profitability. Key ratios include P/B 0.29, price/sales 0.32, and current ratio 2.70, which supports short-term liquidity. Revenue growth last fiscal year was 25.06% and gross margin near 24.11%, but return on equity is negative at -2.36%. These figures explain mixed investor sentiment for 8K7.SI stock despite reasonable asset backing.

8K7.SI stock: Meyka AI grade and analyst framing

Meyka AI rates 8K7.SI with a score out of 100: 63.35 (Grade B, HOLD). This grade factors S&P 500 and sector comparisons, financial growth, metrics, forecasts and analyst consensus. The evaluation highlights decent balance sheet metrics but weak profitability and margin pressure. This grade is informational only and not financial advice. Investors should weigh the Meyka grade alongside company updates and sector trends.

8K7.SI stock: Technicals, liquidity and short-term signals

Momentum signals show RSI 29.14 and MFI 16.51, both in oversold ranges. Bollinger bands are 0.07–0.10, with the price near the lower band. Average price over 50 days is S$0.09138 and 200 days S$0.09990, confirming a downtrend. Given on‑chain volume and OBV at 9,758,200, short sellers may dominate near-term order flow. Traders should monitor a break below S$0.072 or recovery above S$0.090 for directional clues.

8K7.SI stock: Forecasts, price targets and scenarios

Meyka AI’s forecast model projects monthly S$0.080, quarterly S$0.090 and yearly S$0.102. Against the current price of S$0.075, the one‑year implied upside is +35.51% to S$0.102. Forecasts are model-based projections and not guarantees. A downside scenario to S$0.050 implies -33.33% from today. Analysts will watch margin recovery, glove demand and inventory turnover to validate optimistic forecasts for 8K7.SI stock.

8K7.SI stock: Sector context, risks and catalysts

UG Healthcare operates in the Healthcare sector and Medical Instruments industry on the SES in Singapore. The sector average P/E is higher, and peers show stronger ROE and margins. Sector demand for disposable gloves remains cyclical and tied to global trade and PPE orders. Key risks for 8K7.SI stock include inventory build, long cash conversion cycle (CCC 249 days) and thin free cash flow. Catalysts include contract wins, margin improvement and better working capital conversion.

Final Thoughts

UG Healthcare (8K7.SI) ranks among pre-market top losers on 18 Mar 2026 after a 5.06% fall to S$0.075 and higher-than-average volume of 935700. The company shows mixed fundamentals: healthy current ratio 2.70 and low P/B 0.29, but negative EPS -0.01 and weak profitability metrics. Meyka AI rates 8K7.SI with a score out of 100 at 63.35 (Grade B, HOLD), reflecting asset strength but earnings pressure. Meyka AI’s forecast model projects a one‑year target of S$0.102, implying +35.51% upside from current levels, while a downside case to S$0.050 would erase value quickly. Short-term traders should watch a break of S$0.072 or recovery above S$0.090 for directional confirmation. Use this Meyka AI-powered market analysis platform insight with company filings and sector data before acting, as forecasts are model-based projections and not guarantees

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.